immusmol/5-HIAA ELISA试剂盒-尿液-快速通道/BA-E-1900
市场价:
¥5600.00
美元价:
2800.00
产品分类:
封闭血清
公司分类:
Closed_serum
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Product information | Key steps | References | Technical support | Reviews |
Product overview
Product name | 5-HIAA ELISA kit - Urine - Fast-Track |
Description | In vitro diagnostics enzyme immunoassay (ELISA) for the fast determination of 5-HIAA in urine samples. |
Labels | IVD, CE |
Format | 96-well plate |
Samples | 50 µl urine |
Cross specie-reactivity | React with all species |
Standard range | 0 / 0.5 - 50 mg/l |
Sensitivity | 0.17 mg/l |
Specificity | No significant cross-reactivity was observed with 5-HIAA analogs such as Serotonin, 5-Hydroxy-DL-Tryptophan, Tryptamine, Melatonin, 5-Hydroxytryptamin, Vanillic mandelic acid and Homovanillic Acid. |
Assay time | 3 hours |
Storage | Store at 2-8°C for up to 6 months. |
Datasheets | Instructions for use , Material safety datasheet |
Key steps
Sample collection & storage | Spontaneous or 24-hour urine, collected in a bottle containing 10-15 mL of 6 M HCl. Storage: for longer periods (up to 6 months) at -20°C. |
Sample preparation | Sample predilution and methylation (30 min) |
ELISA | 5-HIAA antiserum incubation (1 hour), revelation and read steps (90 min). |
Detailed protocol | Download instructions for use |
References
- Beer TM et al. Acupuncture for Hot Flashes in Patients With Prostate Cancer. Urology. 2010 Nov;76(5):1182-8.
- Jackson LN et al. Development and Characterization of a Novel In vivo Model of Carcinoid Syndrome. Clin Cancer Res. 2009 Apr 15;15(8):2747-55.
Technical SupportSubmit a question
No technical question yet. Be the first to ask!TopReviewsSubmit your review
No reviews yet. Thanks for rating this product.Top品牌介绍
我们的重点:针对小分子的抗体ImmuSmol代表“针对小分子的免疫球蛋白[抗体]”。传统抗体只能识别蛋白质等大分子,而ImmuSmol设计并开发能够靶向低分子量实体(<900 Da)的抗体。因此,氨基酸,脂质,糖类,毒素,药物……实际上,任何小分子都可以以高亲和力和特异性来处理。与现有的基于抗体的技术完全兼容,小分子抗体为研究,诊断和治疗开辟了全新的可能性。三大核心应用研究抗体 -ImmuSmol销售经过验证的 一抗,用于细胞和组织中的小分子检测和可视化。定制服务 -ImmuSmol提供针对小分子的抗体,用于研究,诊断和治疗应用。诊断与治疗 -目前正在开发基于专有小分子抗体的三种个性化医学程序。